Is There a Limerics Vaccine on the Market?

When limerix was on the market, there was a concern among some vaccine recipients that targeting the ospa protein was what led to side effects like achiness and arthritus. But cassandra says, the new vaccine in development from fizer and the french company val neva, avoids the ospe issue entirely. This is in a stage three clinical trial a veiser. And valneva recently said that they want to submit their data to regulators by 20 25. What do you think it would mean to have a lime vaccine on the market in a few years?